Skip to main content
SpringerLink
Log in

Arrhythmias

  • Chapter
  • First Online:
Cardiac Drug Therapy

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 3489 Accesses

Abstract

The rational basis of antiarrhythmic therapy ideally requires a knowledge of:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Ahsan SY, Moon JC, Hayward MP, et al. Constrictive pericarditis after catheter ablation for atrial fibrillation. Circulation. 2008;118:e834–5. 10.1161.

    Article  PubMed  Google Scholar 

  • Alboni P, Tomasi C, Menozzi C, et al. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 2001;37:548–53.

    Article  CAS  PubMed  Google Scholar 

  • Anderson JL, Jolivette DM, Fredell PA. Summary of efficacy and safety of flecainide for supraventricular arrhythmias. Am J Cardiol. 1988;62:62D.

    Article  CAS  PubMed  Google Scholar 

  • Antzelevitch C, Brugada P, Brugada J, et al. Brugada syndrome: 1992–2002: a historical perspective. J Am Coll Cardiol. 2003;41:1665–71.

    Article  PubMed  Google Scholar 

  • Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference: endorsed by the heart rhythm society and the European heart rhythm association. Circulation. 2005;111:659–70.

    Article  PubMed  Google Scholar 

  • Antzelevitch C. Genetic basis of Brugada syndrome. Heart Rhythm. 2007;4:756–7.

    Article  PubMed Central  PubMed  Google Scholar 

  • Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.

    Article  CAS  PubMed  Google Scholar 

  • Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation. 2004;110:1731–7.

    Article  PubMed  Google Scholar 

  • Benditt DG, Dunnigan A, Buetikofer J, et al. Flecainide acetate for long-term prevention of PSVT. Circulation. 1991;83:345.

    Article  CAS  PubMed  Google Scholar 

  • Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol. 1992;20:1391–6.

    Article  CAS  PubMed  Google Scholar 

  • Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 2002;105:73–8.

    Article  PubMed  Google Scholar 

  • Buxton AE, Marchlinski FE, Flores BT, et al. Non-sustained ventricular tachycardia in patients with coronary artery disease: role of electro-physiological study. Circulation. 1986;75:1178.

    Article  Google Scholar 

  • Cappato R, Calkins H, Chen S, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111:1100–5.

    Article  PubMed  Google Scholar 

  • Chockalingam P, Crotti L, Girardengo G, et al. Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. J Am Coll Cardiol. 2012;60:2092–9. doi:10.1016/j.jacc.2012.07.046.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators—the OPTIC Study: a randomized trial. JAMA. 2006;295:165–71.

    Article  CAS  PubMed  Google Scholar 

  • Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. Engl J Med. 2011a;364:806–17.

    Article  CAS  Google Scholar 

  • Connolly SJ, Ezekowitz MD, Yusuf S, et al. The RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51. (RE-LY).

    Google Scholar 

  • Connolly S, Camm AJ, Halperin JL, For the PALLAS Investigators, et al. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med. 2011b;365:2268–76.

    Article  CAS  PubMed  Google Scholar 

  • Delacrétaz E. Supraventricular tachycardia. N Engl J Med. 2006;354:1039–51.

    Article  PubMed  Google Scholar 

  • DiMarco JP, Miles W, Akhtar M. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. Ann Intern Med. 1990;113:104.

    Article  CAS  PubMed  Google Scholar 

  • Ellrodt AG, Murata GH, Riedinger MS, et al. Severe neutropenia associated with sustained release procainamide. Ann Intern Med. 1984;100:197.

    Article  CAS  PubMed  Google Scholar 

  • Eikelboom JW, Weitz JI. New anticoagulants. Circulation. 2010;121:1523–32.

    Article  PubMed  Google Scholar 

  • Francis J, Antzelevitch C. Atrial fibrillation and Brugada syndrome. J Am Coll Cardiol. 2008;51:1149–53.

    Article  PubMed Central  PubMed  Google Scholar 

  • Gladstone DJ, DJ S, Dorian P, et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014;370:2467–77.

    Article  CAS  PubMed  Google Scholar 

  • Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation (ARISTOTLE). N Engl J Med. 2011;365:981–92.

    Article  CAS  PubMed  Google Scholar 

  • Haines DE. Atrial fibrillation ablation in the real world. J Am Coll Cardiol. 2012;59(2):150–2.

    Article  PubMed  Google Scholar 

  • Horowitz LN, Greenspan AM, Spielman SR, et al. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. Am J Cardiol. 1985;55:367.

    Article  CAS  PubMed  Google Scholar 

  • Hussein AA, Saliba WI, Martin DO, et al. Natural history and long-term outcomes of ablated atrial fibrillation. Circ Arrhythm Electrophysiol. 2011;4:271–8.

    Article  PubMed  Google Scholar 

  • Imazio M, Brucato A, Ferrazzi P, et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011a;124:2290–5.

    Article  CAS  PubMed  Google Scholar 

  • Imazio M, Brucato A, Ferrazzi P, et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation. 2011b;22(124):2290–5.

    Article  Google Scholar 

  • Jaeggi E, Chiu C, Hamilton R, et al. Adenosine induced atrial pro arrhythmia in children. Can J Cardiol. 1999;15:169.

    CAS  PubMed  Google Scholar 

  • John RM, Tedrow UB, Koplan BA, et al. Ventricular arrhythmias and sudden cardiac death. The Lancet. 2012;380(9852):1520–9.

    Article  Google Scholar 

  • Josephson ME. Treatment of ventricular arrhythmias after myocardial infarction. Circulation. 1986;74:653.

    Article  CAS  PubMed  Google Scholar 

  • Katritsis DG, Zareba W, John Camm AJ. Nonsustained ventricular tachycardia. J Am Coll Cardiol. 2012;60(20):1993–2004.

    Article  PubMed  Google Scholar 

  • Kaufman ES. Quinidine in short QT syndrome: an old drug for a new disease. J Cardiovasc Electrophysiol. 2007;18:665–6.

    Article  PubMed  Google Scholar 

  • Kerin NZ, Blevins RD, Frumin H, et al. Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias. Am J Cardiol. 1985;55:89.

    Article  CAS  PubMed  Google Scholar 

  • Kubac G, Klinke WP, Grace M. Randomized double blind trial comparing sotalol and propranolol in chronic ventricular arrhythmia. Can J Cardiol. 1988;4:355.

    CAS  PubMed  Google Scholar 

  • Larsson SC, Drca N, Wolk A. Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. J Am Coll Cardiol. 2014;64:281–9.

    Article  CAS  PubMed  Google Scholar 

  • Lazzara R. Amiodarone and torsades de pointes. Ann Intern Med. 1989;111:549.

    Article  CAS  PubMed  Google Scholar 

  • Leenhardt A, Glasser E, Burguera M, et al. Short-coupled variant of torsade de pointes: a new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation. 1994;89:206.

    Article  CAS  PubMed  Google Scholar 

  • Marchlinski FE, Gansher TS, Waxman HL, et al. Amiodarone pulmonary toxicity. Ann Intern Med. 1982;98:839.

    Article  Google Scholar 

  • Mason JW. Drug therapy: amiodarone. N Engl J Med. 1987;316:455.

    Article  CAS  PubMed  Google Scholar 

  • Mattioni TA, Zheutlin TA, Sarmiento JJ, et al. Amiodarone in patients with previous drug-mediated torsade de pointes. Ann Intern Med. 1989;111:574.

    Article  CAS  PubMed  Google Scholar 

  • McGovern B, Hasan G, Malacoff RF, et al. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. Am J Cardiol. 1984;53:1558.

    Article  CAS  PubMed  Google Scholar 

  • Mega JL, Braunwald E, Wiviott SD, et al. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012;366:9–19.

    Article  CAS  PubMed  Google Scholar 

  • Mizusawa Y, Sakurada H, Nishizaki M, et al. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment. J Cardiovasc Pharmacol. 2006;47:359–64.

    CAS  PubMed  Google Scholar 

  • Morady F, Sauve MJ, Malone P, et al. Long-term efficacy and toxicity of high-dose amiodarone therapy for ventricular tachycardia or ventricular fibrillation. Am J Cardiol. 1983;52:975.

    Article  CAS  PubMed  Google Scholar 

  • Naccarelli GV, Fineberg NS, Zipes DP, et al. Amiodarone: risk factors for recurrence of symptomatic ventricular tachycardia identified at electrophysiologic study. J Am Coll Cardiol. 1985;6:814.

    Article  CAS  PubMed  Google Scholar 

  • Nademanee K, Singh BN, Hendrickson J, et al. Amiodarone in refractory life-threatening ventricular arrhythmias. Ann Intern Med. 1983;98:577.

    Article  CAS  PubMed  Google Scholar 

  • Nademanee K, Veerakul G, Nimmannit S, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation. 1997;96:2595–600.

    Google Scholar 

  • Norris RM, Barnaby PF, Brown MA, et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet. 1984;2:883.

    Article  CAS  PubMed  Google Scholar 

  • Opolski G, Torbicki A, Kosior DA, et al. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) study. Chest. 2004;126:476–86.

    Article  PubMed  Google Scholar 

  • Ouyang F, Tilz R, Chun J, et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: lessons from a 5-year follow-up. Circulation. 2010;122:2368–77.

    Article  PubMed  Google Scholar 

  • ROCKET AF, Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.

    Article  CAS  PubMed  Google Scholar 

  • Rankin AC, McGovern BA. Adenosine or verapamil for the acute treatment of supraventricular tachycardia? Ann Intern Med. 1991;114:513.

    Article  CAS  PubMed  Google Scholar 

  • Rankin AC, Pringle SD, Cobbe SM, et al. Amiodarone and torsades de pointes. Am Heart J. 1990a;120:1482.

    Article  Google Scholar 

  • Rankin AC, Pringle SD, Cobe SM. Acute treatment of torsades de pointes with amiodarone: proarrhythmic and antiarrhythmic association of QT prolongation. Am Heart J. 1990b;19:185.

    Article  Google Scholar 

  • Roden DM, Woosley RL. Drug therapy: flecainide. N Engl J Med. 1986;315:36.

    Article  CAS  PubMed  Google Scholar 

  • Rotmensch HH, Elkayam U, Frishman W. Antiarrhythmic drug therapy during pregnancy. Ann Intern Med. 1983;98:487.

    Article  CAS  PubMed  Google Scholar 

  • Ruskin JN. The cardiac arrhythmia suppression trial (CAST). N Engl J Med. 1989;321:85.

    Article  Google Scholar 

  • Shah RU, Freeman JV, Shilane D, et al. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012;59:143–9.

    Article  PubMed  Google Scholar 

  • Smith WM, Gallagher JJ. “Les torsades de pointes”: an unusual ventricular arrhythmia. Ann Intern Med. 1980;93:578.

    Article  CAS  PubMed  Google Scholar 

  • Smith WM, Lubbe WF, Whitlock RM, et al. Long-term tolerance of amiodarone treatment for cardiac arrhythmias. Am J Cardiol. 1986;57:1288.

    Article  CAS  PubMed  Google Scholar 

  • Somberg JC. Antiarrhythmic drags: making sense of the deluge. Am Heart J. 1987;113:408.

    Article  CAS  PubMed  Google Scholar 

  • Steinberg SJ, Mittal S. Intracranial emboli associated with catheter ablation of atrial fibrillation: has the silence finally been broken? J Am Coll Cardiol. 2011;58:689–91.

    Article  PubMed  Google Scholar 

  • Steurer G, Gursoi S, Frey B, et al. Differential diagnosis on the electrocardiogram between ventricular tachycardia and preexcited tachycardia. Clin Cardiol. 1994;17:306.

    Article  CAS  PubMed  Google Scholar 

  • Strickberger SA, Man KC, Daoud EG, et al. Adenosine-induced atrial arrhythmia: a prospective analysis. Ann Intern Med. 1997;127:417–22. Erratum, Ann Intern Med. 1998;128:511.

    Article  CAS  PubMed  Google Scholar 

  • Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation. 1991;4:1831.

    Google Scholar 

  • Tzivoni D, Banai S, Schuger C, et al. Magnesium sulfate therapy for sustained monomorphic ventricular tachycardia. Circulation. 1988;77:392.

    Article  CAS  PubMed  Google Scholar 

  • Van Gelder IC, Groenveld HF, Crijns HJGM, For the RACE II Investigators, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med. 2010;362:1363–73.

    Article  PubMed  Google Scholar 

  • Vaughan Williams EM. Classification of antiarrhythmic drugs. In: Sandhoe E, Flensted-Jensen E, Olesen KH, editors. Symposium on cardiac arrhythmias. Sodertalje: AB Astra; 1970. p. 449.

    Google Scholar 

  • Viskin S, Antzelevitch C, Marquez MF, et al. Quinidine: a valuable medication joins the list of “endangered species”. Europace. 2007;9(12):1105–6.

    Article  PubMed  Google Scholar 

  • Webster G, Berul CI. An update on channelopathies. From mechanisms to management. Circulation. 2013;127:126–40.

    Article  PubMed  Google Scholar 

  • Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol. 2011;57:160–6.

    Article  PubMed  Google Scholar 

  • Wyse DG, Waldo AL, DiMarco JP, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002;347:1825–33.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Ottawa The Ottawa Hospital, Ottawa, ON, Canada

    M. Gabriel Khan MD, FRCPC, FRCP (London), FACC

Authors
  1. M. Gabriel Khan MD, FRCPC, FRCP (London), FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Khan, M.G. (2015). Arrhythmias. In: Cardiac Drug Therapy. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-962-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-962-4_14

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-961-7

  • Online ISBN: 978-1-61779-962-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation